Fortress Biotech, Inc.
NASDAQ:FBIOBiotechnology
Healthcare
$1.77 -1.79%
-$0.06 today
- Market cap
- $59.03M
- Beta
- 1.23
- P/E (TTM)
- 0.7
- EPS (TTM)
- $4.05
52W Low $1.70High $4.53
Volume 0.19M
Average 0.43M
Balance Sheet
Inspect the capital base behind the business.
Assets
$185.55M
FY 2025 · Annual
+28.7% YoYLiabilities
$123.36M
FY 2025 · Annual
-15.4% YoYEquity
$62.18M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 305.74M | 178.27M | 80.93M | 57.26M | 79.38M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 23.79M | 28.35M | 15.39M | 10.4M | 29.94M |
| Inventory | 9.86M | 14.16M | 10.21M | 14.43M | 9.62M |
| Other Current Assets | 0 | 9.66M | 10.5M | 8.28M | 5.05M |
| Total Current Assets | 346.46M | 230.43M | 117.02M | 90.37M | 123.84M |
| Property, Plant & Equipment (Net) | 34.07M | 33.01M | 23.5M | 17.12M | 14.82M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 12.55M | 27.2M | 20.29M | 31.86M | 27.61M |
| Long-term Investments | 2.22M | 2.69M | 2.44M | 1.55M | 17.66M |
| Tax Assets | (2.22M) | (2.69M) | 0 | 0 | 0 |
| Other Non-current Assets | 3.42M | 3.66M | 4.28M | 3.32M | 1.62M |
| Total Non-current Assets | 50.04M | 63.87M | 50.5M | 53.85M | 61.71M |
| Total Assets | 396.5M | 294.3M | 167.53M | 144.22M | 185.55M |
| Account Payables | 47.43M | 57.24M | 34.81M | 31.64M | 14.24M |
| Short-term Debt | 5.32M | 10.18M | 3M | 625K | 0 |
| Tax Payables | 345K | 722K | 843K | 932K | 356K |
| Deferred Revenue | 2.61M | 728K | 0 | 0 | 0 |
| Other Current Liabilities | 34.42M | 46.62M | 9.06M | 4.84M | 2.31M |
| Total Current Liabilities | 101.04M | 127.72M | 84.91M | 71.4M | 49.74M |
| Long-term Debt | 46.56M | 93.14M | 60.86M | 57.96M | 59.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.03M | 1.85M | 1.89M | 1.76M | 1.45M |
| Total Non-current Liabilities | 69.58M | 116.56M | 81.03M | 74.47M | 73.62M |
| Total Liabilities | 170.63M | 244.28M | 165.94M | 145.87M | 123.37M |
| Common Stock | 101K | 110K | 15K | 28K | 32K |
| Retained Earnings | (547.46M) | (634.23M) | (694.87M) | (740.87M) | (734.05M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | (103K) | 0 | 0 | 0 |
| Minority Interest | 117.2M | 8.3M | (20.96M) | (24.38M) | 12.31M |
| Total Equity | 225.88M | 50.03M | 1.59M | (1.64M) | 62.18M |
| Total Debt | 74.98M | 127.34M | 84.66M | 75.96M | 74.3M |
| Net Debt | (230.77M) | (50.92M) | 3.73M | 18.7M | (5.08M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $255.8M |
| Receivables | $25.5M |
| Inventory | $9.3M |
| Other Current | $4.8M |
| Total Current Assets | $295.5M |
| PP&E (Net) | $14.2M |
| Intangible Assets | $26.5M |
| Long-term Investments | $19.9M |
| Other Non-current | $740.0K |
| Total Non-current Assets | $61.4M |
| Total Assets | $356.9M |
Analysis
Selected assets total $356.9M for Latest. The largest visible component is Cash & Equivalents at $255.8M, about 71.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 29, 2026 | |
| 8-K | Current report | Oct 1, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 1, 2026 |
How much cash does FBIO have?
Fortress Biotech, Inc. (FBIO) reported $79.38M in cash and equivalents in fiscal 2025.
How much debt does FBIO carry?
Fortress Biotech, Inc. (FBIO) reported $74.30M of total debt, with net debt of -$5.08M.
Continue the stock analysis
Jump to another research area for this company.